Dalvotoclax
Dalvotoclax (Example 8) is a selective inhibitor of BCL-2. Dalvotoclax has good liver microsomal stability. Dalvotoclax inhibits the activity of anti-apoptotic BCL-2 protein and anti-apoptotic BCL-XL protein. Dalvotoclax can be studied in research for B cell leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2416927-21-2
- Formule: C45H47ClF3N7O8S
- Masse moléculaire:938.41
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 2416927-21-2
-
Masse moléculaire 938.41
-
Formule C45H47ClF3N7O8S
-
SMILES
O=C(C(C=CC(N1CCN(CC(CCC(C)(C2)C)=C2C3=C(Cl)C=C(C(F)(F)F)C=C3)CC1)=C4)=C4OC5=CN=C6NC=CC6=C5)NS(C7=CC([N+]([O-])=O)=C(NC[C@H]8COCCO8)C=C7)(=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)